ANTI OBESITY
India to make drugs for diabetes, obesity under PLI by 2026, says report
India plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a government official speaking to Reuters. These drugs, originally approved for diabetes treatment, are also used for obesity due to their ability to slow digestion and reduce appetite. Novo Nordisk's patent on semaglutide, a key ingredient in popular drugs like Wegovy and Ozempic, is set to expire in India by 2026. Indian companies are already preparing to manufacture these drugs under the government's production-linked incentive (PLI) scheme.
Ozempic frenzy lures rich Indians to brave the gray market
People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying counterfeit formulas online, and importing boxes from Europe. The treatments have sparked extensive media coverage, fueling a high demand. According to Goldman Sachs Research, the anti-obesity medication market could hit $100 billion by 2030. In contrast, Indians have largely been observers in this global frenzy over the new weight-loss solutions.
Anti-diabetic drugs lead growth in pharmaceuticals market
The pharmaceuticals market in India is witnessing significant growth, with anti-diabetic drugs leading the way with over ₹155 crore in value growth among new brands launched in the past year. The respiratory segment and vitamin/mineral/nutrient segment followed closely behind. The anti-diabetes market has grown rapidly in the last five years, driven by factors like the increasing number of patients and the launch of new drug combinations. The pharmaceutical market rebounded in April 2024, with chronic segments showing faster growth compared to acute segments.
New oral diabetes + obesity drug's India sales surge 100%
India experiences a surge in Rybelsus sales, impacting the anti-obesity market. Semaglutide dominates, reflecting India's obesity challenges and evolving disease patterns as it grows as a superpower.
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resort for some. “I would rather go for these short cuts that the pharma industry offers than go under the knife for my appearance,” says Rajput. The drugs — Wegovy and Ozempic — which have the same ingredient, semaglutide, are all the rage ever since entrepreneur Elon Musk tweeted about it.
‘Obese people should opt for a structured programme of diet, exercise & medication’
"Nothing comes without a downside. These molecules do produce significant nausea and vomiting in some people — to the extent that they have to discontinue the medication. Some may develop diarrhoea, some may have severe constipation. Others may not like the way they lose weight—they may feel very shrunken or their face may seem very thinned out. That’s another sort of downside," says Dr Ambrish Mithal, chairman, endocrinology & diabetes, Max Healthcare, Delhi.
- Go To Page 1
Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot
Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.
Anti-obesity drug market gaining traction in India
According to research firm Pharmarack, the market has tripled in two years after witnessing a sluggish growth till 2021. Over the last five years, the market has grown at 32% CAGR to 474 crore in January 2024.
A guide to the anti-cancer diet: Eat more broccoli, feast on some tomatoes
Scientists have a good idea of what foods you should avoid to reduce your risk of cancer, such as red and processed meats, "fast" or processed foods, alcohol and sugary drinks.
Psychology of anti-vegan bias: Why do many people dislike those who eschew meat & dairy?
Studies indicate that people described as vegan are perceived more negatively, as being less likable and participants in studies report being less open to friendship with vegans than non-vegans, on average.
Biggest pharma blockbuster? All about Wegovy, Novo Nordisk's obesity drug, that cuts risk of heart attacks and strokes by 20%
In a groundbreaking achievement, Novo Nordisk's obesity medication Wegovy has not only demonstrated its efficacy in substantial weight loss but has also shown a remarkable reduction in the risk of heart disease.
BMI calculator has its limitations. Obesity medicine physician suggest alternatives for assessing weight & health
The American Medical Association has called on its members to reduce their reliance on the body mass index (BMI) as a measure of health in patients, stating that it does not provide precise information about body fat levels and related health risks.
Saudis ditch kabsa, switch to kale to battle obesity
One in five adults, in Saudi Arabia is reported to be suffering from obesity.
Words can be heavy: 5 things overweight people are tired of hearing
It doesn't cost anything to be nice you know?
Novo Nordisk launches anti-diabetes pill semaglutide in India
Novo Nordisk, the Danish drug maker on Thursday announced the launch of oral semaglutide in India for treatment of type 2 diabetes.
Drugs for treating diabetes, obesity & ageing can potentially be used to treat Covid: Researchers
The scientists believe that natural compounds such as curcumin and resveratrol, among others, and existing drugs such as metformin and Rapamyci have potential to get tested extensively for the treatment of COVID-19 and post-coronavirus syndrome.
How to stay away from heart disease, BP, obesity, diabetes? Answer is in your food
Choose the right anti-inflammatory foods, and you may be able to reduce your risk of illness.
Indians must take a leaf out of UK's anti-obesity drive: Experts believe cycling can make people fit
Covid has restricted people's movements and curtailed fitness regimens.
'Obesity paradox' decoded: Being overweight increases risk of diabetes but helps improve survival in cancer patients
WHO estimates at least 2.8 million people die each year as a result of being overweight or obese.
The superdrink you need: Green tea improves gut health, cuts obesity risk
Catechins, anti-inflammatory polyphenols found in green tea, have been linked to anti-cancer activity.
Over 3K Bengalureans participate in 5K Run for millet awareness
Minister for agriculture Shivashankara Reddy, millet crusader and minister for rural development and panchayatraj Krishna Byre Gowda, Padma Shri and Arjuna awardee for athletics Anju Bobby George attended the event.
Liver problems, sleep apnea, GERD: Obesity can harm more than just the heart
It’s time you looked beyond the cardiovascular risk of obesity.
Zydus Cadila gets USFDA nod to market anti-obesity drug
The product is used together with diet and exercise to treat obesity (overweight) in people with risk factors such as high blood pressure, high cholesterol or diabetes, Zydus Cadila said.
Suffering from obesity-induced pain? Mediterranean diet may help
Anti-inflammatory foods including fish, nuts and beans is key to preventing or reducing the pain.
VLCC launches nationwide campaign ‘Stand Up India’ to fight obesity
VLCC on Thursday launched its annual anti-obesity campaign Stand Up India in a build-up to Anti-Obesity Day on November 26.
How snoring can be injurious to your health
People who snore usually have no problem acknowledging that snoring is disruptive and uncomfortable.
Five ways social media can affect your mental health
We all know how addictive social media can be, but did you know about its impactful on your mental health?
All you need to know about hypertension
In most cases the cause for hypertension is uncertain and this makes it even more important to be alert. Here are some facts about it.
Corona inks agreement with Kitozyme for a fat binder anti-obesity drug
Belgium life science company, Kitozyme entered into in-licensing agreement with Corona Remedies for fat binder anti-obesity drug.
Load More
